📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

In a cohort of individuals with type 2 diabetes using the drug sulfasalazine, HbA1c lowering is associated with haematological changes. (2021)

First Author: N'Dow SMS

Attributed to: Investigation of the target of metformin funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/dme.14463

PubMed Identifier: 33236391

Publication URI: http://europepmc.org/abstract/MED/33236391

Type: Journal Article/Review

Volume: 38

Parent Publication: Diabetic medicine : a journal of the British Diabetic Association

Issue: 9

ISSN: 0742-3071